Y. R. B. M. van Gestel

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Although the efficacy of bevacizumab has been established in patients with metastatic colorectal cancer (mCRC), population-based studies are needed to gain insight into the actual implementation of bevacizumab in daily practice. Since these studies are lacking for patients with metachronous metastases, the aim of this study is to evaluate the current role(More)
  • 1